View Post

Lower dose of oestrogen receptor modulator seems to reduce risk of breast cancer

In Clinical Studies News by Barbara Jacoby

Source: Karolinska Institutet From: While the drug tamoxifen reduces the risk of developing breast cancer and prevents recurrence, the side-effects cause many women to discontinue their treatment. A study involving researchers at Karolinska Institutet in Stockholm has now found that a much lower dose than the standard produces a good effect with fewer adverse reactions in women who have …